{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:45:06Z","timestamp":1792104306471,"version":"4.4.0"},"reference-count":36,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"30","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["J Clin Oncol"],"published-print":{"date-parts":[[2026,10,20]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Circulating tumor DNA (ctDNA) holds promise for prognostication and disease monitoring in solid tumors. However, rare and heterogenous tumors with low mutational burden like soft tissue sarcomas (STS) present a technical challenge for ctDNA analysis. We investigated the ability of personalized ctDNA analysis to predict outcomes and track response to radiotherapy and pembrolizumab in patients with localized STS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We analyzed 313 plasma samples collected pretreatment, postradiotherapy\/presurgery, and postsurgery from 106 patients treated with preoperative radiotherapy with or without perioperative pembrolizumab for high-risk, localized STS in the SU2C-SARC032 phase II randomized trial. Personalized ctDNA assays were designed to track a median of 46 somatic mutations per patient. Associations between ctDNA levels and outcomes were assessed using univariable and multivariable models adjusting for clinical risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Personalized ctDNA profiling detected baseline ctDNA in 85% of patients. Baseline ctDNA levels correlated with tumor size, grade 3 disease, and expression of genes related to hypoxia and the cell cycle. ctDNA levels pretreatment, after radiotherapy with or without immunotherapy but before surgery, and postsurgery were strongly associated with disease-free and overall survival on univariable and multivariable analyses. Patients treated with pembrolizumab, who had significantly better disease-free survival, had a greater decrease in their ctDNA levels after neoadjuvant therapy. Finally, personalized ctDNA analysis enabled noninvasive subclone tracking and patients with multiple tumor clones detected by ctDNA analysis after surgery had inferior outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Tumor-informed, personalized profiling enables sensitive ctDNA detection and quantitative monitoring in localized STS, providing independent prognostic information across the perioperative course. These findings support prospective ctDNA-guided interventional trials in STS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco-26-00769","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:59:36Z","timestamp":1788983976000},"page":"2941-2952","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial"],"prefix":"10.1200","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7892-886X","authenticated-orcid":false,"given":"Ajay","family":"Subramanian","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3075-0223","authenticated-orcid":false,"given":"Serey C.L.","family":"Nouth","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Nemat-Gorgani","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh","family":"Soudi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4492-0357","authenticated-orcid":false,"given":"Karla V.","family":"Ballman","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN"},{"name":"Biostatistics Core, Sarcoma Alliance for Research Through Collaboration, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7785-4579","authenticated-orcid":false,"given":"Rachel S.","family":"Heise","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Johns","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4868-1509","authenticated-orcid":false,"given":"Timothy J.","family":"Sears","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8232-4994","authenticated-orcid":false,"given":"Siyer","family":"Roohani","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"},{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9686-5802","authenticated-orcid":false,"given":"Reinhardt","family":"Krcek","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"},{"name":"Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3668-243X","authenticated-orcid":false,"given":"Angela M.","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Chris O'Brien Lifehouse-Royal Prince Alfred Hospital, Sydney, NSW, Australia"},{"name":"Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent J.","family":"Weinhold","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute, Duke University, Durham, NC"},{"name":"Department of Surgery, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"van de Rijn","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Brigman","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute, Duke University, Durham, NC"},{"name":"Department of Orthopaedic Surgery, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5412-8710","authenticated-orcid":false,"given":"Richard F.","family":"Riedel","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute, Duke University, Durham, NC"},{"name":"Division of Medical Oncology, Department of Medicine, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9839-2414","authenticated-orcid":false,"given":"Yvonne M.","family":"Mowery","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute, Duke University, Durham, NC"},{"name":"Department of Radiation Oncology, UPMC Hillman Cancer Center-University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2086-205X","authenticated-orcid":false,"given":"David G.","family":"Kirsch","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"},{"name":"Duke Cancer Institute, Duke University, Durham, NC"},{"name":"Department of Radiation Oncology, Duke University, Durham, NC"},{"name":"Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada"},{"name":"Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7913-5351","authenticated-orcid":false,"given":"Everett J.","family":"Moding","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Stanford University, Stanford, CA"},{"name":"Stanford Cancer Institute, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_11_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.5828"},{"key":"e_1_3_11_3_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0126"},{"key":"e_1_3_11_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01812-9"},{"key":"e_1_3_11_5_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0634"},{"key":"e_1_3_11_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2013.110"},{"key":"e_1_3_11_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2200075"},{"key":"e_1_3_11_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2511885"},{"key":"e_1_3_11_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.014"},{"key":"e_1_3_11_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30453-x"},{"key":"e_1_3_11_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2023.12.002"},{"key":"e_1_3_11_12_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-0250"},{"key":"e_1_3_11_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2140-0"},{"key":"e_1_3_11_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3520"},{"key":"e_1_3_11_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-03919-2"},{"key":"e_1_3_11_16_2","doi-asserted-by":"crossref","unstructured":"Testa S Himes JE Subramanian A et al: Distinct sarcoma microenvironments predict benefit from addition of pembrolizumab to preoperative radiotherapy and surgery in SU2C-SARC032. 2025. https:\/\/www.medrxiv.org\/content\/10.1101\/2025.11.01.25339299v1","DOI":"10.1101\/2025.11.01.25339299"},{"key":"e_1_3_11_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004"},{"key":"e_1_3_11_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00010-3"},{"key":"e_1_3_11_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0114-6"},{"key":"e_1_3_11_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05776-4"},{"key":"e_1_3_11_21_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-3281"},{"key":"e_1_3_11_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.0528"},{"key":"e_1_3_11_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.3616"},{"key":"e_1_3_11_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01147-6"},{"key":"e_1_3_11_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010157"},{"key":"e_1_3_11_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28885"},{"key":"e_1_3_11_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.03.028"},{"key":"e_1_3_11_28_2","first-page":"941","article-title":"Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma","volume":"56","author":"Brizel DM","year":"1996","unstructured":"Brizel DM, Scully SP, Harrelson JM, et al: Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56:941-943, 1996","journal-title":"Cancer Res"},{"key":"e_1_3_11_29_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0118"},{"key":"e_1_3_11_30_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2299"},{"key":"e_1_3_11_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.04.008"},{"key":"e_1_3_11_32_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-3774"},{"key":"e_1_3_11_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.03.019"},{"key":"e_1_3_11_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.0042"},{"key":"e_1_3_11_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102820"},{"key":"e_1_3_11_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23592"},{"key":"e_1_3_11_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35792"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO-26-00769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:59:27Z","timestamp":1792101567000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO-26-00769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":36,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2026,10,20]]}},"alternative-id":["10.1200\/JCO-26-00769"],"URL":"https:\/\/doi.org\/10.1200\/jco-26-00769","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"2026-03-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}